The Ministry of Health of Lithuania and Japan Agency for Medical Research and Development signed the Memorandum of Cooperation

2017 03 14
LTU ir Japonija.jpg

The Ministry of Health of the Republic of Lithuania and Japan Agency for Medical Research and Development (AMED) signed the Memorandum of Cooperation.

MEMORANDUM OF COOPERATION

BETWEEN

THE MINISTRY OF HEALTH OF THE REPUBLIC OF LITHUANIA

AND

JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT

ON

HEALTH SCIENTIFIC COOPERATION

 

 

The Ministry of Health of the Republic of Lithuania (hereinafter referred to as “MOH of Lithuania”) and Japan Agency for Medical Research and Development (hereinafter referred to as “AMED”)

 

Hereinafter collectively referred to as “Participants” and individually as “Participant”

 

Recognizing the desire of the health scientists in Participants’ respective countries to further enhance and strengthen cooperation;

 

Intending to advance Lithuania-Japan partnership in medical research and development;

 

Noting that this MEMORANDUM OF COOPERATION (hereinafter referred to as “this MOC”) sets out the recognition of the Participants’ intention that the cooperation will promote research collaboration in the scientific fields which the Participants consider important with a view to achieve advancement in medical research and development;

 

Noting that these scientific fields will include, but will not be restricted to:

  1. Exchanges of young biomedical researchers for basic and clinical research;
  2. Rare and undiagnosed diseases;
  3. Oncology; and
  4. Other areas of mutual interest; and

 

Acting within their competence and in compliance with international obligations and laws and regulations in force in the territories of their countries, have decided as follows:

 

 

Section I

 

The purpose of this MOC is to strengthen cooperation between the Participants on scientific research on health and to promote and support cooperation between health scientists in Lithuania and Japan related to medical research and development. This MOC is intended to facilitate medical research cooperation in areas of mutual interest.

 

Section II

 

Activities under this MOC may include, but are not necessarily limited to, the following collaborative activities:

  1. Exchange of information and experiences;
  2. Joint research projects;
  3. Joint conferences and seminars; and
  4. Other cooperative activities as may be decided by Participants.

 

Section III

 

The activities to be carried out under this MOC should meet the following requirements:

  • All collaborative activities should be of high scientific standard and beneficial to the advancement of medical research and development in Lithuania and Japan.
  • All collaborative activities should be of significant benefit to Lithuania and Japan, from a scientific and practical point of view which will benefit from bilateral cooperation.
  • All collaborative activities should be performed on a basis of mutuality.

 

Section IV

 

International Cooperation Division of the MOH of Lithuania intends to be responsible for facilitating and coordinating the participation in activities under this MOC by entities within MOH of Lithuania. The Department of International Affairs of AMED intends to be responsible for facilitating and coordinating the participation in activities under this MOC by entities within AMED.

 

The Participants may utilize other documents for implementation to facilitate specific cooperative activities pursuant to this MOC.

 

Section V

 

Each Participant acknowledges the importance of the protection of human and animal subjects in any research, public health or medical program. Each Participant’s country has adopted laws and regulations on the protection of human and animal subjects involved in research. Each Participant intends to conduct all its activities contemplated by this MOC in line with all laws, regulations, policies and procedures applicable to it.

 

Section VI

 

This MOC is an expression of the current intentions of the Participants and does not create any legally binding obligations. The MOC will not affect rights and obligations of the Participants, arising from international agreements to which their countries are Parties. Specific projects and activities under this MOC are under the approval of the relevant project participants’ managements, the availability of personnel, appropriated funds and other resources.

 

Section VII

 

The Participants intend to encourage scientists involved in activities carried out under this MOC (hereinafter referred to as “Scientists”) to publish their findings, both collaboratively and as individuals. In any publication specifically related to work performed in connection with this MOC, the Scientists should be encouraged to make an appropriate reference to the collaborative activities under this MOC. The Participants intend to make medical outputs available to the wider scientific community and the public, in line with the Participants’ customary practices and procedures.

 

Section VIII

 

This MOC may only be modified and supplemented in writing as decided by mutual written consent of the Participants.

 

Section IX

 

The Participants will attempt to resolve all problems arising from this MOC amicably through discussions.

 

Section X

 

The cooperation under this MOC may commence upon signature of the Participants, and is intended to continue for five (5) years from the date of signing. The cooperation under this MOC is intended to be automatically renewed and continued on a five-year basis unless either of the Participants provides written notice to the other that it wishes to discontinue the cooperation under this MOC at least six (6) months before the expiration of the original or any subsequent terms of this MOC. The Participants intend that the discontinuance of the cooperation under this MOC is not to affect the cooperative projects already being carried out under this MOC.

 

Signed in Vilnius, Lithuania, on March 9th 2017, in two originals, each in the English language.